News | News By Subject | News by Disease News By Date | Search News

Atrial Fibrillation News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Boehringer Ingelheim Corporation's Investigational Antidote For Pradaxa® Grabs FDA Breakthrough Therapy Designation     6/26/2014
Bristol-Myers Squibb Company (BMY)'s Eliquis® Works As Well As Pfizer Inc. (PFE)'s In Head-To-Head Subanalysis Study     3/27/2014
Servier, Xention Limited Sign Potential $163.2 Million Deal to Develop AF Drug     10/3/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey     9/25/2013
Cardiome Pharma Corp. (COM.TO) Announces Publication of Positive Data From a Study Comparing Vernakalant IV Versus Propafenone and Flecainide     9/23/2013
ARCA biopharma, Medtronic, Inc. (MDT) Collaborate on Atrial Fibrillation Trial     4/22/2013
Bristol-Myers Squibb (BMY)-Pfizer (PFE)'s Blood Thinner Eliquis Wins FDA Approval     1/3/2013
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal     11/28/2012
Bristol-Myers Squibb Company (BMY)-Pfizer Inc. (PFE) Anticlot Drug Gets Key EU Approval     11/23/2012
Boehringer Ingelheim Corporation Initiates a Voluntary Recall of a Single Manufacturing Lot of Pradaxa®     11/7/2012
FDA Issues Import Alerts for 22 Chinese Heparin Suppliers     2/24/2012
Bayer HealthCare (BAY)'s Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in Non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis     12/19/2011

News from Around the Web
Booze Daily May Boost Atrial Fibrillation Risk, AHA Study     9/15/2016
Device That Reduces Risk Of Atrial Fibrillation Being Used In Colorado, University Of Colorado Hospital Reveals     3/24/2016
Losing Weight Can Keep Irregular Heartbeat In Check, Intermountain Medical Center Heart Institute Research Finds     11/9/2015
More Evidence Proves Coffee Doesn't Harm Your Heart, Karolinska Institute Study     9/23/2015
Botox May Erase Irregular Heartbeat Issues, State Research Institute Of Circulation Pathology Reveals     5/15/2015
200-Year-Old Heart Drug Linked To Premature Death, European Hearth Journal Reveals     5/7/2015
Fish Oil Supplements Have Little Effect On Irregular Heartbeat, Montreal Heart Institute Study     10/17/2014
Moderate Alcohol Use Associated With Increased Risk For Atrial Fibrillation, Karolinska Institute Study     7/24/2014
New Targeting Technology Improves Outcomes for Patients With Atrial Fibrillation, University of California, Los Angeles (UCLA), University of California, San Diego (UCSD), Indiana University Study     7/19/2012
New Agent Prevents Stroke in Patients With Atrial Fibrillation, Duke Clinical Research Institute Study Suggests     8/11/2011
Study Shows Epleronone to Reduce Atrial Fibrillation, University of Gothenburg Study     5/23/2011
Statins Don't Suppress Afib After Ablation, Mayo Clinic Study Finds     5/9/2011
Biomarker May Predict Adverse Events in Atrial Fibrillation, University of Birmingham Study     4/15/2011
Oxidative Stress May Help Predict Atrial Fibrillation Risk, Emory University School of Medicine Study     4/8/2011
Yoga Stretches Afib Attack Frequency, University of Kansas Study     4/4/2011

Press Releases
Acutus Medical Announces Completion Of Enrollment For UNCOVER AF Study Of AcQMap In Persistent Atrial Fibrillation     4/27/2017
ARCA biopharma Announces 200th Patient Randomized Into The GENETIC-AF Seamless Design Phase IIB/III Clinical Trial     4/26/2017
Medtronic (MDT) Initiates Global Trial Evaluating Cryoablation To Treat Persistent Atrial Fibrillation     3/30/2017
Boehringer Ingelheim Release: Uninterrupted Pradaxa (Dabigatran Etexilate Mesylate) Showed Less Major Bleeding Than Warfarin In Atrial Fibrillation Patients Undergoing Catheter Ablation     3/20/2017
Ex-Google (GOOG) Exec's Stroke Prevention Startup AliveCor Gets $30 Million     3/17/2017
Daiichi Sankyo Initiates ENTRUST-AF PCI Study Investigating Once-Daily SAVAYSA (Edoxaban) In Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention With Stenting     3/6/2017
ARCA biopharma Release: Company Announces 150th Patient Randomized Into The GENETIC-AF Phase IIB/III Clinical Trial     1/18/2017
Boehringer Ingelheim Release: New Data Show High Adherence Rates With Pradaxa (Dabigatran Etexilate Mesylate) In NVAF Patients     12/5/2016
Janssen Pharmaceutical Release: Phase 3b Study Shows Significantly Less Bleeding With XARELTO (Rivaroxaban) Compared To Warfarin In People With Non-Valvular Atrial Fibrillation Following Percutaneous Coronary Intervention With Stenting     11/14/2016
First Data From Boehringer Ingelheim, Anthem And HealthCore Multi-Year Study Show Gaps In Non-Valvular Atrial Fibrillation Care     11/14/2016
Bayer (BAY) And The AHA Collaborate To Advance Cardiovascular Research     11/14/2016
Boehringer Ingelheim Release: Patient Enrollment Completed For RE-DUAL PCI Study Assessing Dabigatran In Atrial Fibrillation Patients After PCI With Stenting     11/11/2016
Acutus Medical Announces First Patient Procedure In Pivotal Atrial Fibrillation Trial (UNCOVER-AF) And Introduction Of The World’s First Electrofunctional Procedure     10/26/2016
Boehringer Ingelheim Release: New Real-World Data Show Pradaxa (Dabigatran Etexilate Mesylate) Treatment Resulted In Less Use Of All-Cause Healthcare Resources Than Warfarin Treatment     10/21/2016
ARCA biopharma Announces Randomization Of First European Patients In GENETIC-AF Phase IIB/III Clinical Trial     10/6/2016